| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $7.48B | +0.5% |
| Cost of Revenue | $6.59B | +0.2% |
| R&D Expense | $12.0M | +200.0% |
| SG&A Expense | $339.0M | -9.1% |
| Operating Income | $563.0M | -24.0% |
| Pre-tax Income | $428.0M | -31.0% |
| Income Tax | $66.0M | -53.8% |
| Net Income | $362.0M | -24.1% |
| EPS (Basic) | $7.23 |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.0M | -40.4% |
| Accounts Receivable | $1.00B | +9.4% |
| Current Assets | $1.15B | +2.0% |
| Total Assets | $5.25B | -1.3% |
| Current Liabilities | $1.40B | +20.6% |
| Long-term Debt | $2.22B | +5.8% |
| Stockholders' Equity | $1.58B | -11.7% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $494.0M | +24.7% |
| Capital Expenditures | $36.0M | +33.3% |
| Investing Cash Flow | -$35.0M | -111.1% |
| Financing Cash Flow | -$498.0M | +31.3% |
| Free Cash Flow | $458.0M | +24.1% |
| -19.5% |
| EPS (Diluted) | $7.17 | -19.3% |